Menu

Contributors

Meet some of the people featured in the May 2018 issue of The Scientist.

May 1, 2018
The Scientist Staff

VICTORIA WILLIAMSJournalist Amanda Keener became interested in science as a 12-year-old, when her youngest brother was diagnosed with a rare genetic disease. “The internet was becoming more available at the time so I would do online searches about his disease, and became really interested in genetics,” she says. She continued to pursue biology in high school and college, and eventually entered a PhD program at the University of North Carolina, Chapel Hill. The program combined microbiology and immunology, and she began studying autoimmune diseases and the connections between autoimmunity and Staphylococcus infections. The “ups and downs” of the graduate program eventually led her to look for career options beyond academia. Without telling her graduate advisor, she started sitting in on an undergraduate journalism class. This led to writing for local newspapers and for a friend’s blog, which gave Keener the confidence she needed to start pursuing a career in science writing. With her advisor’s blessing, she landed an internship at Nature Medicine during her final summer at Chapel Hill. “That was huge because the editor there really helped me learn about the journalism side” of science writing, she says. She has been a freelance writer ever since. Her brother, she reports, is doing fine. Keener writes about whole-exome sequencing and rare disease here.


STEVE BUSKENVictoria Jackson describes herself as a “fearful warrior” who has “always been a survivor in what has come up in [her] life.” In the 1990s, Jackson began marketing a line of cosmetics via infomercials, and over 13 years the company made close to a billion dollars in sales. “That was my entrée into the beauty world, and from there, the business world.” In 2008 her whole world was rocked when her daughter Ali was diagnosed with neuromyelitis optica (NMO), a rare autoimmune disorder that affects the optic nerves and spinal cord. Jackson started the Guthy-Jackson Charitable Foundation with her husband, Bill, to fund research into prevention and treatment for the disorder. As with her business, running the foundation draws on her skills as a human being and as a survivor, says Jackson. “Everything that I did was putting one foot in front of the other,” she says. “You can pretty much do anything that you put your mind to.” She has written four books, including Saving Each Other, which she coauthored with Ali in 2012, and The Power of Rare: A Blueprint for a Medical Revolution, which she wrote with physician Michael Yeaman. Jackson and Yeaman discuss the foundation and how it has driven the evolution of NMO research and treatment here.


"Growing up, all I did was draw,” says Erin Lemieux. These days, she isn’t doing as much sketching and painting as she used to, but as The Scientist’s art director, Lemieux’s talent for design and eye for aesthetics shines on the pages of the magazine each month. Born and raised in Midland, Ontario, Lemieux headed south to Toronto for college, studying graphic design at OCAD University. She was interested in branding and typography, and in her first job after graduating, Lemieux tried her hand at editorial work, doing page layout as a designer at Fizzz Design Corp.

In 2012, Lemieux returned to Midland as a graphic designer at LabX Media Group, which publishes The Scientist, filling in for someone on maternity leave. But she made herself indispensible and was hired permanently to the production team. Her role has changed considerably in the intervening years. Initially she focused on getting the print issue online at the-scientist.com each month, and now she plays a major role in developing infographics, doing page layout, and commissioning illustrators and photographers. In March, Lemieux was promoted to art director. “Seeing the ideas come to life from the people we work with, that’s been really cool.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
BiochemAR: an augmented reality app for easy visualization of virtual 3D molecular models
Have you played Pokemon Go? Then you've used Augmented Reality (AR) technology! AR technology holds substantial promise and potential for providing a low-cost, easy to use digital platform for the manipulation of virtual 3D objects, including 3D models of biological macromolecules.